PURPOSE: To evaluate relationships between retinal vessel caliber and tests of visual function among people with AIDS. DESIGN: Longitudinal, observational cohort study. METHODS: We evaluated data for participants without ocular opportunistic infections at initial examination (baseline) in the Longitudinal Studies of the Ocular Complications of AIDS (1998-2008). Visual function was evaluated with best-corrected visual acuity, Goldmann perimetry, automated perimetry (Humphrey Field Analyzer), and contrast sensitivity (CS) testing. Semi-automated grading of fundus photographs (1 eye/participant) determined central retinal artery equivalent (CRAE), central retinal vein equivalent (CRVE), and arteriole-to-venule ratio (AVR) at baseline. Multiple linear regression models, using forward selection, sought independent relationships between indices and visual function variables. RESULTS: Included were 1250 participants. Smaller AVR was associated with reduced visual field by Goldmann perimetry (P = .003) and worse mean deviation (P = .02) on automated perimetry and possibly with worse pattern standard deviation (PSD) on automated perimetry (P = .06). There was a weak association between smaller AVR and worse CS (P = .07). Relationships were independent of antiretroviral therapy and level of immunodeficiency (CD4+ T lymphocyte count, human immunodeficiency virus [HIV] RNA blood level). On longitudinal analysis, retinal vascular indices at baseline did not predict changes in visual function. CONCLUSIONS: Variation in retinal vascular indices is associated with abnormal visual function in people with AIDS, manifested by visual field loss and possibly by reduced CS. Relationships are consistent with the hypothesis that HIV-related retinal vasculopathy is a contributing factor to vision dysfunction among HIV-infected individuals. Longitudinal studies are needed to determine whether changes in indices predict change in visual function. Copyright Â
PURPOSE: To evaluate relationships between retinal vessel caliber and tests of visual function among people with AIDS. DESIGN: Longitudinal, observational cohort study. METHODS: We evaluated data for participants without ocular opportunistic infections at initial examination (baseline) in the Longitudinal Studies of the Ocular Complications of AIDS (1998-2008). Visual function was evaluated with best-corrected visual acuity, Goldmann perimetry, automated perimetry (Humphrey Field Analyzer), and contrast sensitivity (CS) testing. Semi-automated grading of fundus photographs (1 eye/participant) determined central retinal artery equivalent (CRAE), central retinal vein equivalent (CRVE), and arteriole-to-venule ratio (AVR) at baseline. Multiple linear regression models, using forward selection, sought independent relationships between indices and visual function variables. RESULTS: Included were 1250 participants. Smaller AVR was associated with reduced visual field by Goldmann perimetry (P = .003) and worse mean deviation (P = .02) on automated perimetry and possibly with worse pattern standard deviation (PSD) on automated perimetry (P = .06). There was a weak association between smaller AVR and worse CS (P = .07). Relationships were independent of antiretroviral therapy and level of immunodeficiency (CD4+ T lymphocyte count, human immunodeficiency virus [HIV] RNA blood level). On longitudinal analysis, retinal vascular indices at baseline did not predict changes in visual function. CONCLUSIONS: Variation in retinal vascular indices is associated with abnormal visual function in people with AIDS, manifested by visual field loss and possibly by reduced CS. Relationships are consistent with the hypothesis that HIV-related retinal vasculopathy is a contributing factor to vision dysfunction among HIV-infected individuals. Longitudinal studies are needed to determine whether changes in indices predict change in visual function. Copyright Â
Authors: Tien Yin Wong; Michael D Knudtson; Ronald Klein; Barbara E K Klein; Stacy M Meuer; Larry D Hubbard Journal: Ophthalmology Date: 2004-06 Impact factor: 12.079
Authors: M Kamran Ikram; Simone de Voogd; Roger C W Wolfs; Albert Hofman; Monique M B Breteler; Larry D Hubbard; Paulus T V M de Jong Journal: Invest Ophthalmol Vis Sci Date: 2005-04 Impact factor: 4.799
Authors: Gary N Holland; Peter J Kappel; Mark L Van Natta; Frank J Palella; Alice T Lyon; Kayur H Shah; Peter R Pavan; Douglas A Jabs Journal: Am J Ophthalmol Date: 2010-05 Impact factor: 5.258
Authors: Paul Mitchell; Harry Leung; Jie Jin Wang; Elena Rochtchina; Anne J Lee; Tien Y Wong; Ronald Klein Journal: Ophthalmology Date: 2005-02 Impact factor: 12.079
Authors: Ronald Klein; Barbara E K Klein; Scot E Moss; Tien Y Wong; Larry Hubbard; Karen J Cruickshanks; Mari Palta Journal: Arch Ophthalmol Date: 2004-01
Authors: Ning Cheung; Sophie L Rogers; Kim C Donaghue; Alicia J Jenkins; Gabriella Tikellis; Tien Yin Wong Journal: Diabetes Care Date: 2008-06-03 Impact factor: 19.112